BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2159545)

  • 1. The Epstein-Barr virus (EBV) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z.
    Gruffat H; Moreno N; Sergeant A
    J Virol; 1990 Jun; 64(6):2810-8. PubMed ID: 2159545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R.
    Chevallier-Greco A; Gruffat H; Manet E; Calender A; Sergeant A
    J Virol; 1989 Feb; 63(2):615-23. PubMed ID: 2536097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.
    Chavrier P; Gruffat H; Chevallier-Greco A; Buisson M; Sergeant A
    J Virol; 1989 Feb; 63(2):607-14. PubMed ID: 2536096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.
    Urier G; Buisson M; Chambard P; Sergeant A
    EMBO J; 1989 May; 8(5):1447-53. PubMed ID: 2548844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators.
    Kenney S; Holley-Guthrie E; Mar EC; Smith M
    J Virol; 1989 Sep; 63(9):3878-83. PubMed ID: 2548003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
    Quinlivan EB; Holley-Guthrie EA; Norris M; Gutsch D; Bachenheimer SL; Kenney SC
    Nucleic Acids Res; 1993 Jul; 21(14):1999-2007. PubMed ID: 8393562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.
    Buisson M; Manet E; Trescol-Biemont MC; Gruffat H; Durand B; Sergeant A
    J Virol; 1989 Dec; 63(12):5276-84. PubMed ID: 2555554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an enhancer-type sequence that is responsive to Z and R trans-activators of Epstein-Barr virus.
    Shimizu N; Sakuma S; Ono Y; Takada K
    Virology; 1989 Oct; 172(2):655-8. PubMed ID: 2552665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
    Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
    J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
    Cox MA; Leahy J; Hardwick JM
    J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein.
    Gruffat H; Manet E; Rigolet A; Sergeant A
    Nucleic Acids Res; 1990 Dec; 18(23):6835-43. PubMed ID: 2175879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals.
    Ryon JJ; Fixman ED; Houchens C; Zong J; Lieberman PM; Chang YN; Hayward GS; Hayward SD
    J Virol; 1993 Jul; 67(7):4006-16. PubMed ID: 8389916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL; Kenney SC
    Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
    Sung NS; Kenney S; Gutsch D; Pagano JS
    J Virol; 1991 May; 65(5):2164-9. PubMed ID: 1850003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.
    Carey M; Kolman J; Katz DA; Gradoville L; Barberis L; Miller G
    J Virol; 1992 Aug; 66(8):4803-13. PubMed ID: 1321270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression by RAZ of Epstein-Barr virus bZIP transcription factor EB1 is dimerization independent.
    Segouffin C; Gruffat H; Sergeant A
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1529-36. PubMed ID: 8757996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators.
    Manet E; Gruffat H; Trescol-Biemont MC; Moreno N; Chambard P; Giot JF; Sergeant A
    EMBO J; 1989 Jun; 8(6):1819-26. PubMed ID: 2548857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the 12-O-tetradecanoylphorbol-13-acetate-responsive enhancer of the MS gene of the Epstein-Barr virus.
    Liu Q; Summers WC
    J Biol Chem; 1992 Jun; 267(17):12049-54. PubMed ID: 1318308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1.
    Flemington E; Speck SH
    J Virol; 1990 Mar; 64(3):1217-26. PubMed ID: 2154605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.